Allakos Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
ALLK on Nasdaq
Industry
Pharmaceutical Preparations
Location
825 Industrial Road, Suite 500, San Carlos, CA

There are no Buy or Sell transactions made by insiders since 10/5/2024

Allakos Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Daniel Janney Director $22.6M May 25, 2023
Craig A. Paterson Chief Medical Officer $809K Dec 4, 2023
Mark Asbury CLO, GC and Secretary $567K Mar 2, 2022
Margaret Nell Fitzgerald General Counsel and Secretary $383K Sep 2, 2022
Chin Hyok Lee Chief Medical Officer $311K Dec 4, 2024
Henrik Rasmussen Chief Medical Officer $252K Jun 3, 2021
Bvf Partners L P/Il 10%+ Owner $0 May 15, 2025
Adam Tomasi President $0 May 15, 2025
Paul Edward Walker Director $0 May 15, 2025
Robert Alexander Chief Executive Officer, Director $0 May 15, 2025
Harlan Baird Radford Chief Financial Officer $0 May 15, 2025
Dolca Thomas Director May 15, 2025
Ladd Amy L Director May 15, 2025
Robert E. Andreatta Director May 15, 2025
Everett Rand Sutherland Director Aug 1, 2023
Natalie Holles Director May 25, 2021
John P. Mckearn Director May 25, 2022
Neil Murray Hamilton Graham Director May 15, 2025
Steven P. James Director May 15, 2025
Alta Partners Management VIII, LLC 10%+ Owner Aug 16, 2023

Recent Insider Transactions by Companies or Individuals for Allakos Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.